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Two diagnostic tests, an Aspergillus-specific PCR and an enzyme-linked immunosorbent assay (ELISA) for
the quantitative determination of galactomannan, were compared for diagnosing and monitoring invasive
pulmonary aspergillosis. Persistently neutropenic rats with left-sided invasive pulmonary aspergillosis were
sacrificed at regular intervals after inoculation. Blood samples and bronchoalveolar lavage (BAL) fluid
were cultured and tested by PCR as well as by ELISA. Disseminated fungal infection in extrapulmonary organs
was determined. The sensitivity of the ELISA was higher than that of the PCR on all days of measurements,
in both blood and BAL fluid. Positive PCR or ELISA results in blood were not significantly associated with
disseminated fungal infection. Serial testing in a separate group of rats showed consistently increasing
concentrations of circulating galactomannan during the course of disease, while a positive PCR could be
followed by negative results. The concentration of galactomannan was highly predictive for the time of survival
(P < 0.0001). It was concluded that, in this model, quantitative galactomannan detection is superior to PCR
in diagnosing and monitoring invasive pulmonary aspergillosis.
The incidence of invasive pulmonary aspergillosis (IPA) has
increased considerably in the past decade, and this infection is
now a major cause of morbidity and mortality in immunocom-
prised hosts (9). Patients with prolonged chemotherapy-
induced neutropenia and transplant recipients receiving long-
term, high-dose corticoid therapy are at greatest risk (2). Al-
though mortality rates of IPA remain high despite the use of
antifungal therapy, observations suggest that the mortality rate
may be reduced by early diagnosis and treatment (1, 6). How-
ever, no method has proven sufficiently sensitive and specific to
allow a diagnosis at an early stage (22), and new diagnostic
methods are therefore under investigation.
Methods for the molecular and serological diagnosis of IPA
in blood or bronchoalveolar lavage (BAL) fluid have drawn
particular attention. Using a PCR method for detecting As-
pergillus-specific nucleotide sequences, Einsele et al. (7) found
a 77% sensitivity in patients with IPA prior to antifungal ther-
apy, the sensitivity increasing to 100% when two blood samples
were analyzed. Among the techniques based on antigen de-
tection, the sandwich enzyme-linked immunosorbent assay
(ELISA) for the detection of galactomannan (GM) is currently
the most promising. Studies in neutropenic patients report
sensitivities of between 70 and 90% when applying the test to
serum (4, 19, 21). It must be noted, however, that in these
clinical studies it is often not indicated how early during the
course of the disease the test becomes positive in relation to
the development of clinical and radiological signs. Actually,
clinical investigations into the sensitivity and specificity of tests
for IPA are hampered by the absence of proven infection in
many patients and by the fact that the time of onset of infection
cannot be determined.
In the present study, PCR (two separate assays) and GM
detection were evaluated in a rat model of IPA that has been
developed in our laboratory (12). Using this animal model, we
were able to compare both tests in the early phase of the
disease, with a known time of onset of the infection. In addi-
tion, we determined the value of these tests for monitoring the
course of the disease.
MATERIALS AND METHODS
Infection model of IPA. The animal model used was as described previously
(12), with some modifications to lengthen the survival time. Specific-pathogen-
free female RP strain albino rats (18 to 25 weeks old, 185 to 225 g) were used.
Neutropenia was induced by intraperitoneal (i.p.) administration of cyclophos-
phamide (Sigma-Aldrich Chemie, Steinheim, Germany) at 75 mg/kg 5 days
before inoculation, followed by repeated doses of cyclophosphamide at 60 mg/kg
i.p. 1 day before and 3 and 7 days after inoculation. This protocol resulted in
granulocyte counts of less than 108/liter on the day of inoculation. To prevent
bacterial superinfections, animals received ciprofloxacin (660 mg/liter) and poly-
myxin B (100 mg/liter) in their drinking water during the entire experiment.
Starting 1 day before inoculation, daily intramuscular (i.m.) doses of amoxicillin
(40 mg/kg/day) were added to this regimen for the remainder of the experiment.
On the day of inoculation, gentamicin (6 mg/kg) was added i.m. to the regimen.
For infection of the rats a strain of Aspergillus fumigatus was used that was
originally isolated from an immunocompromised patient with IPA.
While the animals were under general anesthesia, the left main bronchus was
intubated. A cannula was passed through the tube, and the left lung was inocu-
lated with 2 3 104 A. fumigatus conidia. This resulted in a one-sided IPA. The
mortality rate was 650% on day 7 and 90 to 100% on day 12 after inoculation.
At the end of the experiments or at the indicated intervals, rats were sacrificed
and the left lung, as well as the right lung, liver, spleen, and brain, were homog-
enized and cultured to determine the presence of disseminated fungal infection.
In approximately half of the rats, fungal dissemination to extrapulmonary organs
occurred, especially to the liver. Blood cultures for Aspergillus species always
remained negative in this model.
Blood sampling and BAL. Groups of rats were sacrificed to obtain blood for
PCR and GM detection and to determine the presence of disseminated fungal
infection. While the animals were under CO2 anesthesia, blood samples were
taken by cardiac puncture. Bronchoalveolar lavage (BAL) was performed by
exposing the trachea and lavaging the lungs three times with 5 ml of phosphate-
buffered saline (PBS). Of the BAL sample, 2 ml was used for culture, 1 ml was
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used for PCR, and 300 ml was used for GM detection. To monitor the course of
disease in individual rats, sequential blood sampling was performed by puncture
of the orbital plexus.
PCR. Two different methods were used for the extraction of fungal DNA from
fluids: an in-house method developed in our laboratory by van Deventer et al.
(21) and a method of Einsele et al. (7, 13, 14), with some modifications.
DNA extraction from fungal suspensions and BAL fluid. In the in-house
method, 1 ml of fungal suspension or BAL fluid was centrifuged at 16,000 3 g for
5 min. Pellets were resuspended in 0.2 ml of TEG buffer (50 mM glucose, 25 mM
Tris-HCl [pH 8.0], 10 mM EDTA) containing 1.5 ml of lyticase (900 U/ml; Sigma
Chemical Co., St. Louis, Mo.) and then incubated for 1 h at 37°C. Subsequently,
3.0 ml of pronase (15 mg/ml; Boehringer GmbH, Mannheim, Germany) and 10
ml of 10% sodium dodecyl sulfate (SDS) were added, followed by incubation for
1 h at 37°C. The sample containing fungal DNA was further purified.
In the method according to Einsele et al., 1 ml of fungal suspension or BAL
fluid was centrifuged (16,000 3 g, 10 min) and the pellet resuspended in 0.2 ml
of white blood cell lysis buffer (WCLB; 10 mM Tris [pH 7.6], 10 mM EDTA, 50
mM NaCl, 0.2% SDS, 200 mg of proteinase K per ml), followed by incubation at
65°C for 45 min. After centrifugation (1,500 3 g, 10 min), the pellet was resus-
pended in 0.2 ml of zymolyase buffer (50 mM Tris [pH 7.5], 10 mM EDTA, 28
mM b-mercaptoethanol, and 300 mg of zymolyase [20T; ICN, Costa Mesa, Calif.]
(per ml) and incubated at 37°C for 45 min. The solution was centrifuged (1,500 3
g, 10 min), and the pellet containing fungal DNA was further purified.
DNA extraction from blood specimens. In the in-house method of van De-
venter, 0.5 ml of lysis buffer (0.32 M sucrose, 10 nM Tris-HCl [pH 7.5], 5 mM
MgCl2, 1% Triton X-100) was added to 0.5 ml of EDTA-blood. After lysis,
samples were centrifuged (5 min, 16,000 3 g) and the supernatant was discarded.
The pellet was resuspended in 0.2 ml of lysis buffer. To remove free, nonfungal
DNA, 7 ml of DNase 1 (10 mg/ml; Boehringer GmbH) was added and the
samples were incubated at 37°C for 1 h. After centrifugation at 16,000 3 g for 5
min, pellets were resuspended in 0.2 ml of TEG buffer containing 1.5 ml of
lyticase (900 U/ml) and incubated for a further 1 h at 37°C. Subsequently, 3.0 ml
of pronase and 10 ml of 10% SDS were added, followed by incubation for 1 h at
37°C. The sample containing fungal DNA was further purified.
In the method of Einsele et al., 1.5 ml of red blood cell lysis buffer (RCLB; 10
mM Tris [pH 7.6], 5 mM MgCl2, 10 mM NaCl) was added to 0.5 ml of EDTA-
blood, and then the mixture was incubated on a shaking platform for 10 min. The
sample was centrifuged (1,200 3 g, 10 min), and the pellet was treated again with
1.5 ml of RCLB and centrifuged. Subsequently, the pellet was resuspended in 0.2
ml of WCLB and incubated at 65°C for 45 min. After centrifugation (1,500 3 g,
10 min), the pellet was resuspended in 0.2 ml of zymolyase buffer and incubated
at 37°C for 45 min. The sample was centrifuged (1,600 3 g, 10 min), and the
pellet containing fungal DNA was used for further purification.
Purification and amplification of DNA. DNA was purified according to the
method of Boom et al. (3). Briefly, 1 ml of lysis buffer (0.1 M Tris-HCl [pH 6.4],
40 mM EDTA [pH 8.0], 1% Triton X-100, 4 M guanidine isothiocyanate) and 50
ml of a Celite suspension (200 mg/ml; Aoroa Organics, Grel, Belgium) was added
to the sample or pellet containing fungal DNA, and this suspension was shaken
vigorously by hand, followed by incubation at room temperature for 10 min. The
suspension was centrifuged (1 min, 15,000 3 g), and the pellet was washed two
times with a second lysis buffer (0.1 M Tris-HCl [pH 6.4], 4 M guanidine
isothiocyanate), two times with 70% ethanol, and one time with acetone, in
succession. After it was dry, the pellet was resuspended in 100 ml of bidistilled
water and incubated for 10 min at 56°C. The sample was centrifuged (15,000 3
g, 10 min), and 10 ml of the supernatant was used for amplification.
The following primer set, amplifying a sequence of the multicopy 18S rRNA
gene, was used: 59-ATTGGAGGGCAAGTCTGGTG-39 and 59-CCGATCCCT
AGTCGGCATAG-39 (7). PCR was performed in 100 ml of PCR solution con-
taining 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2.5 mM MgCl2, 200 mM con-
centrations of each deoxynucleoside triphosphate, 50 pmol of each primer, 0.08
U of Taq polymerase (SuperTAQ; Sphaero Q, Leiden, The Netherlands), and a
10-ml sample specimen. Forty cycles of amplification were performed with a PCR
processor (9600; Perkin-Elmer). Each cycle consisted of a denaturation step at
95°C for 30 s, a primer-annealing step at 55°C for 30 s, and a chain elongation
step at 72°C for 45 s.
Southern blot analysis of products. Aliquots (20 ml) of each amplification
product were electrophoretically separated on a 1.5% agarose gel in 0.53 Tris-
borate-EDTA buffer. The DNA was transferred from agarose to Hybond-Plus
nylon filters (Amersham International, Amersham, United Kingdom) by elec-
trophoretic transfer (17). The PCR products were analyzed with an Aspergillus-
specific DNA probe (CATGGCCTTCACTGGCTGTGGGGGGAACCA) (7).
Hybridization was detected by the ECL3 oligolabeling and detection system
(Amersham International).
Sandwich ELISA for detection of GM. The sandwich ELISA was performed as
described by Stynen et al. (18) and was used to measure the concentrations of
GM quantitatively. Some minor modifications were made in the protocol to
reduce the standard deviation in series of samples that were spiked with the same
concentration of GM. Briefly, 300 ml of each serum or BAL fluid sample was
mixed with 100 ml of treatment solution (4% EDTA), and the mixture was
subsequently boiled for 5 min. After centrifugation (20,000 3 g, 10 min), the
supernatant was used for further testing. Then, 50 ml of conjugate was added to
each well of an anti-GM immunoglobulin M-coated microtiter plate (Platelia
Aspergillus; Sanofi Diagnostics Pasteur), followed by the addition of 50 ml of the
treated sample. The plates were incubated at 37°C for 90 min and then washed
five times with washing buffer (Tris NaCl [pH 7.4] containing 1% Tween 20 and
0.01% sodium merthiolate). Next, 200 ml of substrate buffer containing ortho-
phenylenediamine dihydrochloride was added to each well, and the plates were
incubated for 30 min at room temperature in darkness. To stop the reaction, 100
ml of 1.5 M sulfuric acid was added, and the optical density was measured at 450
and 620 nm. Each plate contained a calibration curve consisting of rat serum
samples containing 0, 1, 1.5, 2, 3, 4, 6, 8, and 12 ng of GM (the kind gift of Marc
Tabouret, Sanofi Diagnostics Pasteur, Steenvoorde, France) per ml. A test sam-
ple was considered positive when the optical density at 450 nm was higher than
the cutoff sample (i.e., 1.0 ng). The concentration of GM in positive test samples
was expressed as the nanograms of GM per milliliter.
Statistical methods. Associations between GM concentrations and PCR re-
sults or disseminated fungal infection were analyzed by the Mann-Whitney test.
The association between the PCR result and the disseminated fungal infection
was analyzed by using the chi-square test. Spearman’s correlation was used to
analyze relations between GM concentrations and time to death.
RESULTS
Validation of two DNA isolation methods. Two methods
were used for isolating Aspergillus DNA from blood: an in-
house-developed method (21) and the method described of
Einsele et al. (7), with modifications. The in vitro sensitivities
of both methods were compared by isolating fungal DNA from
blood spiked with 10-fold serial dilutions of A. fumigatus
conidia. The isolated DNA was then amplified, and the ampli-
fication product was hybridized with an Aspergillus-specific
probe. Using both DNA isolation methods, 10 CFUs per ml of
rat blood could be detected. The sensitivity was not influenced
by using larger blood volumes: when volumes of 0.1, 0.5, or 2.5
ml of blood were spiked with equal concentrations of conidia,
no increase in sensitivity was seen.
Validation of quantitative ELISA. The commercially avail-
able “Platelia” sandwich ELISA for detecting GM was vali-
dated for quantitative use in rat serum. Concentrations of 0, 1,
1.5, 2, 3, 4, 6, 8, and 12 ng of GM per ml were spiked sixfold
into rat serum. In Fig. 1 the resulting calibration curve is
presented. In all samples tested, linear concentration response
curves were obtained at between 1 and 8 ng/ml (r 5 0.994). The
detection limit, defined as the concentration corresponding to
the mean optical density of the blank plus three standard
deviations (SD), was 1.0 ng/ml.
PCR and ELISA in blood and association with disseminated
fungal infection in rats with IPA. Five groups of rats (the
number of animals in each group varied from 11 to 29) were
sacrificed on days 1, 2, 3, 5, and 7 after inoculation (Table 1).
Control animals (three to nine rats per group) were inoculated
with PBS. From each rat a blood sample was taken for PCR as
FIG. 1. Representative callibration curve of the sandwich ELISA, prepared
in sixfold dilutions with known concentrations of GM in rat serum. Each point
represents the mean 6 the SD (bars) optical density at 450 nm. The detection
limit of the assay is indicated as a dashed line.
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well as for ELISA. The presence of disseminated fungal infec-
tion was determined by the culture of organs. In all 97 blood
samples taken from infected rats, the in-house DNA isolation
method was used, and in 68 of these samples the Einsele et al.
method was also used. Both methods showed the same results
in 66 samples. Results of the in-house PCR are shown in Table
1. PCR had a considerably lower sensitivity than ELISA, es-
pecially between days 2 and 5 after inoculation. The highest
rates of positivity for both tests were found on the last day of
sampling (day 7): 41% for PCR and 100% for ELISA. The
median concentrations of GM increased from below the de-
tection limit in rats on day 1 to 46 ng/ml in rats on day 7. Of all
97 samples, 62% were positive for ELISA; 18% were positive
for PCR, all of these latter samples being also positive for
ELISA. Specificity was high for both tests: of the 31 blood
samples taken from uninfected animals, none were found pos-
itive by the ELISA and only 1 of 31 samples was positive by
PCR.
Results for rats on day 7 were further analyzed to investigate
associations between PCR, the concentration of GM, and the
presence of disseminated fungal infection. The median con-
centration of GM in blood samples that were positive by PCR
was higher (48.0 ng/ml; range, 8.3 to 602 ng/ml) than the
median concentration in PCR-negative samples (30.4 ng/ml;
range, 1.9 to 480 ng/ml). Although there was a trend, this
difference was not significant (P 5 0.09). On day 7, 38% of the
rats showed disseminated infection in the extrapulmonary or-
gans; in all cases the liver was the affected organ. The percent-
age of rats with a positive PCR result was higher (57%) in rats
with disseminated fungal infection than in rats with pulmonary
infection alone (27%). In addition, higher concentrations of
GM were found in rats with disseminated fungal infection
(median, 50.1 ng/ml; range, 1.9 to 602 ng/ml) than in rats
without disseminated infection (median, 15.8 ng/ml; range,
21.0 to 294 ng/ml). However, both associations were not sig-
nificant (P 5 0.35 and 0.14, respectively).
PCR, ELISA, and fungal culture of BAL fluid and blood in
rats with IPA. Four groups of rats (five to eight animals per
group) were sacrificed on days 1, 3, 5, and 7 after inoculation,
respectively (Table 2). From each rat, blood and BAL fluid
were used for PCR, ELISA, and fungal culture analyses. The
blood cultures were all negative. The fungal cultures of BAL
fluid were all positive on day 1 after inoculation, with the
numbers of CFUs decreasing over time. Most BAL fluid cul-
tures obtained from rats on days 5 and 7 after inoculation
remained negative. The PCR results were not related to the
culture findings: one to two positive samples were found on all
days. Four rats (two on day 1, one on day 5, and one on day 7)
were found to be negative in blood and positive in BAL fluid
by PCR. ELISA of BAL fluid was more often positive on days
5 and 7, with increasing titers of GM over time, despite the
negative cultures. Three rats (two on day 1 and one on day 5)
were negative by ELISA of blood but positive for the BAL
fluid.
Monitoring the course of disease by PCR. Ten rats with IPA
were sequentially sampled on days 1, 3, 5, and 7 after inocu-
lation for PCR (Table 3). All rats were found to be negative by
PCR on day 1 after inoculation. On day 3 four of ten rats were
found to be positive by PCR; on day 5 two of eight and on day
7 two of four were found to be positive. No clear increase in the
rate of positive PCR tests was seen during the course of the
disease. Some rats (animals 1 and 10) remained negative for
PCR at all time points, even immediately prior to death. Two
other rats (animals 6 and 8) were positive at day 3 but were
found to be negative thereafter.
Monitoring the course of disease by GM concentrations.
Nine infected rats were sequentially sampled for GM detection
(Fig. 2). A consistent increase in signal was seen during the
course of disease. On day 1 all rats were GM negative; on day
3 all rats were positive by ELISA, and the median concentra-
tion of GM was 9.3 ng/ml. On days 5 and 7 the median con-
centrations increased to 25.8 and 53.0 ng/ml, respectively. Two
rats with relatively high concentrations of GM (71 and 240
ng/ml) on day 5 died the next day. One rat with a relatively low
concentration of GM on day 7 survived relatively long com-
pared to other rats and ultimately died on day 11. We inves-
tigated the relationship between the concentration of GM and
the time to death. An inverse relation was found that was
highly significant (P , 0.0001) (Fig. 2).
DISCUSSION
In the present study, we compared two diagnostic tests,
Aspergillus-specific PCR and a sandwich ELISA for detecting
GM, with respect to their value in diagnosing and monitoring
IPA in a rat model. By using an animal model, both tests could
be evaluated in a controlled fashion in the early phase of the
disease, with a known time of onset of infection.
TABLE 1. PCR and ELISA analyses of blood and association with
disseminated fungal infection in rats with IPA after dissection
Day No. ofanimals
No. of animals
positive (%)
Median concn
(ng/ml) of GM
(range)
Disseminationb
(no. of rats
positive [%])PCRa ELISA
1 24 0 (0) 2 (8) ,1 (,1–3) 0 (0)
2 11 0 (0) 3 (27) ,1 (,1–7) 0 (0)
3 18 2 (22) 16 (89) 7 (,1–31) 0 (0)
5 15 3 (20) 14 (93) 19 (,1–217) 0 (0)
7 29 12 (41) 29 (100) 46 (1.9–600) 11 (38)
a In-house PCR method.
b Extrapulmonary disseminated fungal infection.
TABLE 2. PCR, ELISA, and fungal culture analyses of BAL fluid and blood of rats with IPA after dissectiona
Day No. ofanimals
BAL fluid Blood
PCR
(no. of rats
positive)
ELISA
(no. of rats
positive)
Median concn
(ng/ml) of GM
(range)
Culture
(no. of rats positive
[mean CFU/ml])
PCR
(no. of rats
positive)
ELISA
(no. of rats
positive)
Median concn
(ng/ml) of GM
(range)
Culture
(no. of rats positive
[mean CFU/ml])
1 8 2 2 ,1 (,1–2.7) 8 (4) 0 0 ,1 (,1) 0 (0)
3 5 1 2 ,1 (,1–11) 3 (1) 1 3 4.4 (,1–6.2) 0 (0)
5 5 2 5 11.6 (5.4–157) 0 (0) 1 4 10.2 (,1–26.2) 0 (0)
7 5 1 5 8.8 (3.9–114) 1 (0) 2 5 19.2 (7.6–48) 0 (0)
a The in-house PCR method was used.
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For the diagnosis of IPA in blood, we used two PCR meth-
ods, including the method described by Einsele et al. (7).
Those authors found a 77 to 100% sensitivity in patients with
IPA. In our model of severe IPA, the maximum sensitivity that
was found using both methods was only 41% at a moment at
which more than 50% of the rats had already died (i.e., day 7
after inoculation). One explanation for this difference in sen-
sitivity might be the relatively low blood volume (0.5 ml) used
for PCR in our model compared to the blood volume of 3 to 5
ml used in the study of Einsele et al. Those authors suggested
that a larger blood volume might help to increase the sensitiv-
ity of the assay due to the higher yield of fungal DNA. How-
ever, when we compared different blood volumes (range, 0.1 to
2.5 ml) obtained from infected rats, we did not observe any
increase in sensitivity. Moreover, a higher blood volume may
contain more competing DNA or other inhibiting substances
which may interfere with the specific PCR signal (5). In addi-
tion, the in vitro sensitivities of both of the PCR methods we
used was 10 CFUs per ml, which was similar to the test results
as described by Einsele et al.
Compared to PCR, the sensitivity of the sandwich ELISA in
serum was high in our rat model: up to 100% on day 7. In
addition, the ELISA was positive earlier than was the PCR
assay. No blood samples from infected animals were PCR
positive and ELISA negative. This leads to the conclusion that,
at least in our rat model, PCR is not only less sensitive than
ELISA but also has no additional value to the ELISA in the
diagnosis of IPA.
In monitoring the course of the disease, PCR showed incon-
sistent results in the sequentially sampled rats. No clear in-
crease in the fraction of positive animals was seen over time
with this assay. Also, an on-off phenomenon was observed:
some rats that were positive by PCR became negative at a later
stage in their disease. In the PCR methods we used, fungal
DNA was extracted from the pellet obtained after blood cell
lysis. Since the pellet contains fungal elements, whereas free
DNA may be present in the serum, our method could fail to
detect circulating free DNA. It is possible that a PCR assay in
which circulating DNA is detected in serum gives a better
correlation with fungal load and severity of disease thus gives
more consistent results (4, 10). Comparison of PCR assays in
serum with PCR methods as used in our study should be
investigated in future studies.
In contrast to PCR in our model, concentrations of GM
increased consistently in the course of the disease, which has
also been reported by others in a rabbit model (15). In addi-
tion, we found a highly significant inverse relation between the
concentration of GM and the time to death of the rats. These
findings indicate that the concentrations of GM in serum are
correlated with the severity of the disease in our model and,
possibly, with the fungal load.
Several other studies have compared PCR and GM detec-
tion for the diagnosis of IPA in blood. Hashimoto et al. com-
pared PCR, a (1 3 3) b-D-glucan assay, and GM detection in
a rat model of IPA (10). In their study the sensitivity of PCR
was higher (80 to 87%) in the early phase of the disease than
that of the (1 3 3) b-D-glucan assay (60 to 75%) or of GM
detection (71 to 80%). They also found similar results in a
study in patients: 70% sensitivity for PCR and 60% for GM
detection (23). However, comparison of their findings with our
data is difficult, since they used a latex agglutination test for
detecting circulating GM, an assay which is about 10 times less
sensitive than the sandwich ELISA that we used (21). Also,
they used a different PCR method, i.e., a nested PCR in serum.
Possibly, a nested PCR is more sensitive than conventional
PCR. However, it has been stated that nested PCR is more
prone to contamination in a routine hospital laboratory when
it is used as a diagnostic tool (16). Bretagne et al. compared
GM detection by sandwich ELISA with a PCR in the sera of
patients with IPA (4). These authors, as we found in our
animal study, reported a higher sensitivity for the ELISA than
for the PCR: of the 18 patients with positive mycological data,
78% had at least two ELISA-positive sera and 50% had at least
one PCR-positive serum. They also found only one sample that
was positive for PCR and negative for ELISA, and they noted
that a PCR-positive signal was usually obtained when ELISA
was highly positive. This result is in accordance with our own
data: we found no samples that were ELISA negative and PCR
positive, and the median concentration of GM tended to be
higher in PCR-positive samples. Finally, Roth et al. compared
PCR by using the method described by Einsele et al. and GM
detection by sandwich ELISA in 34 neutropenic patients, of
whom 6 had proven IPA (J. Roth, E. Engelmann, M. Mielke,
and D. Huhn, Abstr. 9th Eur. Congr. Clin. Microbiol. Infect.
Dis., abstr. O45, 1999). In that study GM detection provided
both a higher sensitivity and more consistent results during the
course of disease than did PCR.
In our model, the yield of fungal cultures of BAL fluid
significantly decreased during the course of disease. Positive
results of early cultures were probably related to conidia inoc-
FIG. 2. GM in the blood of individual rats with IPA after sequential sam-
pling. One line represents one rat. (Inset) Relationship between GM concentra-
tions and time to death.
TABLE 3. PCR analysis of blood of 10 individual rats
with IPA after sequential sampling
Rat
PCR results on:
Day 1 Day 3 Day 5 Day 7 Day 81
1 2 2 2 Died on day 7
2 2 2 1 Died on day 7
3 2 1 Died on day 5
4 2 2 1 Died on day 7
5 2 1 1 1 Died on day 8
6 2 1 2 2 Died on day 8
7 2 2 2 1 Died on day 13
8 2 1 2 Died on day 6
9 2 2 NDa 2 Died on day 10
10 2 2 2 Died on day 6
a ND, not determined.
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ulated into the left lung. In contrast, the GM assay was more
often positive later in the disease. Francis et al. found compa-
rable results in a rabbit model of IPA. In their model, cultures
of BAL fluid were rarely positive, in contrast to elevated levels
of mannitol and GM (8). These findings are in accordance with
results reported by Kauffman et al. (11), who investigated the
nature of antigenic determinants released by conidia and hy-
phae. These authors found that components that are released
spontaneously from conidia are only weakly positive or nega-
tive in immunologic assays, in contrast to components released
from hyphae. Thus, it is likely that a strongly immunogenic
molecule such as GM is released predominantly from hyphae
and in much lesser amounts from conidia. Therefore, the pres-
ence of GM in BAL fluid is likely to be a better diagnostic
indicator for hyphal growth than is routine mycological culture
of the organism.
In conclusion, we demonstrated that quantitative GM de-
tection in our model of IPA is superior to PCR in diagnosing
as well as in monitoring the disease in both blood and BAL
fluid.
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